English to Russian Medical Medical: Pharmaceuticals

However, all mice showed progression after discontinuation of chemotherapy.
In the combination plus maintenance setting, addition of intermittent ХХХХ 0.68, 1.36, or 2.73 mg/kg twice daily (BID) during chemotherapy and as subsequent single-agent maintenance therapy increased objective response rates (ORR; PR+CR) in all dose levels and significantly delayed relapses during ХХХХ monotherapy
(A).
After completion of maintenance treatment, 6 out of 9 animals were still tumor-free on Day 45 in the intermittent ХХХХ 2.73 mg/kg BID group.